Imodium® (loperamide) – New boxed warning
November 3, 2016 – The FDA approved the addition of a Boxed Warning to the Imodium (loperamide) drug label. The information pertains to prolongation of the QT interval, torsades de pointes, other ventricular arrhythmias, cardiac arrest, some resulting in death, that have been reported in adults with use of higher than recommended dosages of loperamide.
Top